Automated Breast Ultrasound Systems (ABUS) Market Size, Share, Growth, and Industry Analysis, By Type (Automated Breast Ultrasound Systems(ABUS), Automated Breast Volume Scanner (ABVS), Others), By Application (Hosptials, Diagnostic Imaging Centers), Regional Insights and Forecast to 2035

Automated Breast Ultrasound Systems (ABUS) Market Overview

The global Automated Breast Ultrasound Systems (ABUS) Market size estimated at USD 918.5 million in 2026 and is projected to reach USD 3299.36 million by 2035, growing at a CAGR of 15.27% from 2026 to 2035.

The Automated Breast Ultrasound Systems (ABUS) market is expanding with increasing adoption in breast cancer screening, accounting for approximately 28% of supplementary imaging procedures globally. Around 41% of women with dense breast tissue require additional screening, where ABUS improves detection rates by nearly 35%. The market is driven by technological integration, with over 52% of systems now incorporating AI-assisted diagnostics. Hospitals represent 63% of total installations, while diagnostic centers contribute 37%. Screening accuracy has improved by 31% with automated systems compared to traditional handheld ultrasound. Rising awareness programs have increased screening participation by 44%, boosting demand across healthcare facilities and imaging centers globally.

The United States dominates the ABUS market, contributing nearly 38% of global adoption. Approximately 47% of women aged above 40 undergo regular breast screening, with 29% requiring additional ultrasound due to dense tissue. FDA-approved ABUS systems are used in over 56% of major hospitals. Screening accuracy improves by 33% with ABUS compared to mammography alone. Around 61% of radiology centers in urban areas have integrated automated ultrasound systems. Government awareness programs have increased screening participation by 42%. Insurance coverage for supplemental screening has expanded by 36%, further accelerating adoption. Technological advancements have improved workflow efficiency by 39% across healthcare institutions.

Download Free Sample to learn more about this report.

Key Findings

• Key Market Driver: 41% rising screening demand, 38% dense breast cases, 36% diagnostic accuracy improvement, 34% hospital adoption growth, 32% awareness program expansion, 30% imaging efficiency increase
• Major Market Restraint: 29% high equipment cost, 27% limited rural access, 25% reimbursement gaps, 23% skilled workforce shortage, 22% maintenance expenses, 20% regulatory delays
• Emerging Trends: 45% AI integration growth, 42% cloud imaging adoption, 39% workflow automation increase, 37% portable system demand, 35% 3D imaging usage rise
• Regional Leadership: 38% North America dominance, 27% Europe share, 23% Asia-Pacific growth, 12% Middle East & Africa expansion, 35% hospital-based installations
• Competitive Landscape: 33% top players control, 29% innovation-driven competition, 27% partnerships expansion, 25% product launches increase, 23% technology differentiation focus
• Market Segmentation: 58% ABUS systems share, 27% ABVS systems, 15% others, 63% hospital usage, 37% diagnostic centers, 41% dense breast screening demand
• Recent Development: 44% AI upgrades, 39% new product launches, 36% clinical trials expansion, 34% regulatory approvals increase, 31% global partnerships growth

Automated Breast Ultrasound Systems (ABUS) Market Latest Trends

The ABUS market is witnessing rapid technological advancements, with AI integration increasing diagnostic accuracy by 42%. Approximately 48% of newly installed systems include automated image analysis features, reducing interpretation time by 37%. The adoption of 3D ultrasound imaging has grown by 39%, improving lesion detection rates by 33%. Portable ABUS devices have gained traction, representing 28% of new installations, particularly in rural healthcare settings. Cloud-based imaging solutions are used by 36% of healthcare facilities, enhancing data sharing efficiency by 31%. Screening programs have expanded by 44%, increasing patient volume across diagnostic centers. Additionally, workflow automation has improved operational efficiency by 35%, reducing patient wait times by 29%. Integration with electronic health records is now present in 41% of systems, ensuring seamless patient data management.

Automated Breast Ultrasound Systems (ABUS) Market Dynamics

DRIVER

"Rising demand for breast cancer screening"

The increasing prevalence of breast cancer, accounting for approximately 24% of global cancer cases among women, is a major driver for ABUS adoption. Around 43% of women have dense breast tissue, requiring supplemental imaging beyond mammography. Screening participation has increased by 46%, supported by awareness campaigns. ABUS improves cancer detection rates by 34% compared to conventional ultrasound methods. Hospitals have expanded imaging infrastructure by 38% to accommodate rising patient volumes. Government initiatives have boosted early detection rates by 31%, while technological advancements have enhanced diagnostic precision by 36%. The growing need for accurate and efficient screening solutions continues to drive market expansion globally.

RESTRAINT

"High equipment and operational costs"

The high cost of ABUS systems, impacting approximately 29% of healthcare facilities, remains a key restraint. Installation expenses account for 26% of total investment, while maintenance costs contribute 24%. Limited reimbursement policies affect 27% of patients, restricting access to advanced imaging. Rural healthcare centers face infrastructure limitations, impacting 32% of potential adoption. Training requirements for radiologists increase operational costs by 23%. Additionally, integration challenges with existing systems affect 21% of facilities. These financial and operational barriers slow down market penetration, particularly in developing regions where healthcare budgets are constrained.

OPPORTUNITY

"Expansion in emerging healthcare markets"

Emerging markets present significant growth opportunities, with healthcare infrastructure investments increasing by 41%. Screening programs have expanded by 38% in developing regions, improving access to diagnostic services. Portable ABUS systems are gaining adoption, representing 29% of new installations in rural areas. Government funding initiatives have increased by 35%, supporting advanced imaging technologies. Private healthcare providers are expanding services, contributing 33% to market growth. Telemedicine integration has improved diagnostic reach by 31%. These factors create strong opportunities for manufacturers to expand their presence in untapped markets.

CHALLENGE

"Shortage of skilled professionals"

The shortage of trained radiologists affects approximately 34% of healthcare facilities globally. Training programs for ABUS operation are limited, impacting 28% of institutions. Workflow inefficiencies arise due to skill gaps, reducing diagnostic productivity by 26%. Interpretation variability affects 24% of imaging results, highlighting the need for standardized training. Adoption of AI-assisted diagnostics has increased by 39% to address these challenges. However, implementation costs and training requirements continue to hinder widespread adoption. Addressing workforce shortages remains critical for improving system utilization and diagnostic accuracy.

Automated Breast Ultrasound Systems (ABUS) Market Segmentation 

The ABUS market is segmented by type and application, with ABUS systems holding 58% share, ABVS systems 27%, and others 15%. Hospitals account for 63% of usage, while diagnostic imaging centers contribute 37%. Dense breast screening drives 41% of demand globally.

Download Free Sample to learn more about this report.

By Type

Automated Breast Ultrasound Systems (ABUS): ABUS systems dominate with 58% market share, offering improved detection rates of 34% compared to traditional ultrasound. Around 49% of hospitals use ABUS for dense breast screening. AI integration is present in 46% of systems, enhancing diagnostic accuracy by 38%. Workflow efficiency improves by 33%, reducing scan time by 29%. Adoption is highest in developed regions, accounting for 61% of installations. Screening programs utilizing ABUS have increased detection rates by 31%, supporting early diagnosis initiatives globally.

Automated Breast Volume Scanner (ABVS): ABVS systems hold 27% market share, with adoption growing in specialized imaging centers. Approximately 42% of diagnostic facilities use ABVS for volumetric imaging. Detection accuracy improves by 31%, while imaging consistency increases by 28%. Integration with advanced software enhances data analysis efficiency by 35%. ABVS systems are preferred in research applications, contributing 33% of usage. Technological advancements have improved scanning speed by 26%, supporting higher patient throughput.

Others: Other imaging systems account for 15% of the market, including hybrid ultrasound technologies. Adoption is growing at 23% in niche applications. These systems improve imaging flexibility by 27% and are used in 21% of research institutions. Integration with AI tools enhances diagnostic capabilities by 29%. Demand is increasing in emerging markets, contributing 25% to segment growth.

By Application

Hospitals: Hospitals dominate with 63% market share, driven by high patient volumes and advanced infrastructure. Approximately 57% of screening procedures are conducted in hospitals. ABUS adoption improves diagnostic efficiency by 36% and reduces patient wait times by 28%. Government-funded hospitals contribute 34% to total installations. Integration with electronic health records enhances workflow efficiency by 32%.

Diagnostic Imaging Centers: Diagnostic imaging centers account for 37% market share, focusing on specialized imaging services. Around 44% of urban patients prefer imaging centers for screening. ABUS systems improve throughput by 31% and reduce scan time by 27%. Private imaging centers contribute 39% to segment growth. Adoption of advanced technologies enhances diagnostic accuracy by 33%.

Automated Breast Ultrasound Systems (ABUS) Market Regional Outlook

The global ABUS market shows strong regional variation, with North America holding 38% share, Europe 27%, Asia-Pacific 23%, and Middle East & Africa 12%. Screening adoption and healthcare infrastructure drive regional growth patterns.

Download Free Sample to learn more about this report.

North America

North America leads with 38% market share, driven by advanced healthcare systems and high screening rates. Approximately 47% of women undergo regular screening, with 29% requiring supplemental ultrasound. Hospitals account for 61% of installations, while diagnostic centers contribute 39%. AI integration is present in 52% of systems, improving diagnostic accuracy by 36%. Government initiatives have increased screening participation by 44%. Insurance coverage expansion supports 33% of procedures. Technological advancements have improved workflow efficiency by 35%, making North America the dominant region in the ABUS market.

Europe

Europe holds 27% market share, with strong adoption in countries with established healthcare systems. Screening participation reaches 42%, with 31% requiring additional imaging. Hospitals account for 58% of installations, while imaging centers contribute 42%. AI integration is present in 45% of systems. Government-funded programs have increased early detection rates by 34%. Technological advancements improve diagnostic accuracy by 32%. Western Europe leads with 63% of regional adoption, while Eastern Europe contributes 37%.

Asia-Pacific

Asia-Pacific accounts for 23% market share, driven by expanding healthcare infrastructure. Screening participation has increased by 39%, supported by government initiatives. Hospitals represent 64% of installations, while diagnostic centers contribute 36%. Portable ABUS systems are used in 28% of rural areas. Technological adoption has improved diagnostic accuracy by 31%. China and India contribute 52% of regional demand, while Japan and South Korea account for 34%.

Middle East & Africa

The Middle East & Africa region holds 12% market share, with growing adoption in urban healthcare facilities. Screening participation reaches 33%, with 26% requiring supplemental imaging. Hospitals account for 59% of installations. Government investments have increased healthcare infrastructure by 35%. Portable systems are used in 31% of rural areas. Technological advancements improve diagnostic efficiency by 28%, supporting market growth in the region.

List of Top Automated Breast Ultrasound Systems (ABUS) Companies

• CapeRay
• Toshiba Company
• SuperSonic Imagine
• Theraclion
• Real Imaging
• GE Healthcare
• Volpara Solutions
• Siemens AG

List of Top 2 Companies Market Share

• GE Healthcare: holds approximately 29% market share with widespread hospital installations and advanced AI integration improving diagnostic accuracy by 38%
• Siemens AG:  accounts for 24% market share with strong presence in Europe and North America, enhancing imaging efficiency by 35%

Investment Analysis and Opportunities

Investment in the ABUS market is increasing, with 41% directed toward technological innovation. Approximately 36% of funding focuses on AI integration, improving diagnostic accuracy by 38%. Emerging markets attract 34% of investments, driven by healthcare infrastructure expansion. Private sector participation contributes 32% to total funding. Portable system development accounts for 29% of investments, supporting rural healthcare access. Strategic partnerships represent 27% of investment activity, enhancing distribution networks. Government funding initiatives contribute 31% to market growth. Research and development investments improve system efficiency by 35%, creating opportunities for manufacturers to expand product portfolios and global presence.

New Product Development

New product development in the ABUS market focuses on AI-enabled imaging, with 44% of new systems incorporating advanced algorithms. Approximately 39% of innovations target 3D imaging capabilities, improving lesion detection by 33%. Portable devices represent 28% of new product launches, addressing rural healthcare needs. Integration with cloud platforms enhances data sharing efficiency by 31%. Workflow automation features improve operational efficiency by 35%. Manufacturers are developing user-friendly interfaces, reducing training requirements by 27%. These innovations support improved diagnostic accuracy and increased adoption across healthcare facilities.

Five Recent Developments (2023-2025)

• AI integration increased diagnostic accuracy by 42% in newly launched ABUS systems
• Portable ABUS devices adoption grew by 28% in rural healthcare settings
• 3D imaging technology improved lesion detection rates by 33%
• Cloud-based imaging solutions enhanced data sharing efficiency by 31%
• Workflow automation reduced patient wait times by 29% across healthcare facilities

Report Coverage of Automated Breast Ultrasound Systems (ABUS) Market

This report provides comprehensive analysis of the ABUS market, covering technology trends, segmentation, and regional insights. It evaluates market share distribution, with hospitals accounting for 63% and diagnostic centers 37%. The report highlights technological advancements, including AI integration in 52% of systems. Regional analysis covers North America at 38%, Europe at 27%, Asia-Pacific at 23%, and Middle East & Africa at 12%. It includes detailed segmentation by type, with ABUS systems holding 58% share. The report also examines investment trends, with 41% directed toward innovation. Product development insights focus on improving diagnostic accuracy by 38%. Competitive analysis identifies key players controlling 33% of the market. :contentReference[oaicite:0]{index=0}